Tubular peptide hypermetabolism and urinary ammonia in chronic renal failure in man: a maladaptive response?
Excessive renal tubular peptide uptake and degradation reflecting hypercatabolism may be a maladaptive response in chronic renal failure (CRF). It may also offer an explanation for the increased ammoniagenesis, per surviving nephron, observed in CRF but as yet unexplained. Neither has been explored in man. We have shown in patients with normal renal function and heavy (>5.0 g/24 h) proteinuria that tubular catabolism of a technetium-labelled peptide marker, aprotinin, and urinary ammonia were increased compared to others with less proteinuria. We now measure tubular kinetics of aprotinin and urinary ammonia in 16 CRF patients with variable proteinuria. Metabolism and turnover of aprotinin and ammonia excretion were increased, corrected for glomerular filtration rate, to levels found in patients with normal function and heavy proteinuria.
Rustom
R
R
Regional Renal Unit, Royal Liverpool University Hospital, UK.
Maltby
P
P
Grime
J S
JS
Hughes
A
A
Costigan
M
M
Shenkin
A
A
Critchley
M
M
Bone
J M
JM
D000143:Acids / Q000652:urine; D000328:Adult; D000368:Aged; D000641:Ammonia / Q000652:urine*; D007611:Aprotinin / Q000493:pharmacokinetics / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D007684:Kidney Tubules / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000378:metabolism*; D013670:Sodium Pertechnetate Tc 99m / Q000493:pharmacokinetics
D000143:Acids; D000641:Ammonia; D007611:Aprotinin; D013670:Sodium Pertechnetate Tc 99m